I can't comment on the American process. I don't know what the American process is. I will just say that the Canadian process is focused on two things. First of all is the safety of the vaccines, and obviously what every Canadian expects is that the regulators will do their due diligence to ensure that the vaccines are safe and that they're effective as per the manufacturers' claims.
We have doubled the capacity, if not more, of the regulatory department. We have teams of regulators for each vaccine that are ready to review that data, and in fact are reviewing a lot of the data already. As I said, these rolling reviews allow for regulators to review data as it arrives, as opposed to having it all at the conclusion of the clinical trials.
We're well positioned to be working with the manufacturers to review the data as they produce it.